2280:TADAWULAlmarai Company Analysis
Data as of 2026-03-11 - not real-time
SAR 43.20
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Almarai’s stock trades at SAR 43.2, well below its DCF‑derived fair value of SAR 55.99, implying an upside of roughly 34%. The price sits just above the 20‑day SMA (SAR 42.05) but remains under the 200‑day SMA (SAR 46.48), signaling a short‑term technical bias while the longer‑term trend stays bearish. Momentum indicators are mixed: the MACD histogram is positive (0.30) and the signal line is bullish, yet the overall trend direction is flagged as bearish. Trading volume is on an increasing trajectory, supporting the potential for a breakout toward the resistance at SAR 43.98. Volatility over the past 30 days stands at 23%, and the beta of 0.03 indicates the stock moves almost independently of the broader market, reducing systematic risk. Fundamentally, revenue grew 5.8% year‑over‑year to SAR 22.1 bn, with solid gross (31%) and operating margins (12.5%).
The company delivers a dividend yield of 2.31% with a payout ratio near 40%, which, combined with positive operating cash flow, suggests the dividend remains sustainable despite a negative free‑cash‑flow figure. Its debt‑to‑equity ratio of 63.5% is elevated, but the strong cash position (SAR 0.52 bn) and robust earnings (EPS 2.46) provide a cushion. Valuation multiples—PE 17.6x and PB 2.08x—are modest relative to peers in the consumer‑defensive segment, reinforcing the undervalued label. Analyst consensus leans heavily toward a ‘strong‑buy’ with a mean target price of SAR 57.9, underscoring market optimism. The Fear & Greed Index reads ‘Extreme Greed’ at 77.6, reflecting bullish sentiment that may be pricing in future upside. Taken together, the blend of defensive sector positioning, attractive dividend, and significant valuation gap makes Almarai a compelling candidate for medium‑ to long‑term accumulation.
The company delivers a dividend yield of 2.31% with a payout ratio near 40%, which, combined with positive operating cash flow, suggests the dividend remains sustainable despite a negative free‑cash‑flow figure. Its debt‑to‑equity ratio of 63.5% is elevated, but the strong cash position (SAR 0.52 bn) and robust earnings (EPS 2.46) provide a cushion. Valuation multiples—PE 17.6x and PB 2.08x—are modest relative to peers in the consumer‑defensive segment, reinforcing the undervalued label. Analyst consensus leans heavily toward a ‘strong‑buy’ with a mean target price of SAR 57.9, underscoring market optimism. The Fear & Greed Index reads ‘Extreme Greed’ at 77.6, reflecting bullish sentiment that may be pricing in future upside. Taken together, the blend of defensive sector positioning, attractive dividend, and significant valuation gap makes Almarai a compelling candidate for medium‑ to long‑term accumulation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support level
- mixed technical signals (MACD bullish but trend bearish)
- increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- substantial valuation upside (~34%)
- steady dividend yield and sustainable payout
- moderate revenue growth and defensive sector
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- defensive consumer‑defensive positioning
- strong brand and diversified product portfolio
- sustainable dividend supported by operating cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth5.80%
Profit Margin11.13%
P/E Ratio17.6
ROE12.50%
ROA5.10%
Debt/Equity63.52
P/B Ratio2.1
Op. Cash FlowSAR5.5B
Free Cash FlowSAR-1587767552
Technical Analysis
TrendBearish
RSI56.4
SupportSAR 38.18
ResistanceSAR 43.98
MA 20SAR 42.05
MA 50SAR 42.72
MA 200SAR 46.48
MACDBullish
VolumeIncreasing
Fear & Greed Index77.64
Valuation
Fair ValueSAR 56.00
Target PriceSAR 57.92
Upside/Downside34.08%
GradeUndervalued
TypeBlend
Dividend Yield2.31%
Risk Assessment
Beta0.03
Volatility23.36%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.